Feed

Lennar Toll Brothers

Analysts Keefe, Bruyette & Woods upgraded Toll Brothers (TOL) to outperform with a target price of $161, while downgrading Lennar (LEN) to underperform with a target price of $86

Keefe, Bruyette & Woods has downgraded Lennar while upgrading Toll Brothers, reflecting a K-shaped recovery in the housing market that favors affluent buyers over entry-level consumers. This divergence highlights the contrasting outlooks for these two homebuilders amid ongoing economic pressures.
SpaceX Merck Redwire Eli Lilly

The Pharmaceutical Industry Embraces Space: Drug Development in Low Earth Orbit Gains Momentum

The shift of pharmaceutical development to lower Earth orbit represents a significant evolution in the space economy, with the potential to enhance drug formulation and delivery methods. This trend could disrupt traditional pharmaceutical practices and create new investment opportunities as the space economy is projected to exceed $1 trillion by 2040.